Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery | NCT01021163 | Trialant
CompletedInterventionalPhase 4Updated Nov 26, 2009
Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery
ClinicalTrials.gov ID
NCT01021163
Lead Sponsor
Yonsei UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
48Actual
Last Update Posted
Nov 26, 2009Estimated
Brief Summary
The purpose of this study is to study the effects of N-acetylcysteine on pulmonary function in high-risk patients undergoing off-pump coronary bypass surgery.
Coronary Artery Occlusion
N-acetylcysteine, saline
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Adult patients with Euroscore ≥ 5
Exclusion Criteria:
Patients in need of emergency surgery,acute renal failure patients, kidney transplanted patients, patients injected with NAC 5days before planned surgery